Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of sumatriptan, acetaminophen, and ketorolac for acute migraine pain relief and patient satisfaction
IRCT20110814007327N8Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in migraine comparing Subcutaneous sumatriptan, Intravenous acetaminophen and Intravenous ketorolac (3 arms). Primary endpoint: Pain relief. Started May 2019; status: completed.
02
Drugs
sumatriptanacetaminophenketorolac
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20110814007327N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110814007327N8.